Connect with us

Femtech World Awards

Femtech World Awards to honour life-changing fertility innovations



The innovations transforming reproductive medicine and giving hope to millions of prospective parents across the globe are being recognised in the Femtech World Awards.

The inaugural awards are looking for the teams and organisations creating innovative solutions to reshape fertility treatment and improve access to care.

Infertility is a global health issue affecting millions of people of reproductive age worldwide. About 17.5 per cent of the global adult population – roughly one in six – will experience infertility at some point in their lifetime, according to the World Health Organization, showing the urgent need to increase access to affordable, high-quality fertility care for those in need.

Through the Fertility Innovation Award, sponsored by Apryl, the Femtech World Awards aim to shine a light on the life-changing work of those developing next-generation innovations that could not only increase success rates but revolutionise the world of reproductive health as we know it.

Apryl is a fertility benefits platform that helps employers attract and retain top talent while tackling diversity and inclusion. The company helps employers support their employees with fertility and family planning benefits, including consultation, access to clinics, treatments and adoption.

Jenny Saft, co-founder and CEO, said: “Being a part of the Femtech World Awards is a great opportunity to stand at the forefront of innovation and progress. It’s here that we witness the transformative power of technology in reshaping women’s health, a cause close to my heart.

“The awards represent a milestone in recognising the advancements in women’s health technology. We’re thrilled to be involved in celebrating the ingenuity and dedication of those who are breaking barriers and creating solutions in an area once overlooked.

“This event is a testament to the potential of technology in empowering women’s health and wellbeing worldwide.”

Femtech World editor, Sorina Mihaila, added: “The science surrounding research on embryos means that new, innovative technologies appear on our radar every day.

“We are looking forward to showcasing the emerging stars in the fertility space at our first Femtech World Awards.”

Find out more about the awards and enter for free here

Femtech World Awards

Four inspirational leaders shortlisted for Femtech World award



Four inspirational leaders have been shortlisted for the Femtech World Leader of the Year award, sponsored by IVF 2.0.

IVF2.0 is a UK-based company which uses AI to improve IVF outcomes. Its tools help embryologists better select oocytes, embryos and sperm to ease workload and increase pregnancy success rates.

The company has a strong research background, peer reviewed publications and experienced leadership.

The team will judge the four submissions for the Leader of the Year category, with the winner announced at a virtual ceremony on May 2.

Congratulations to the shortlist for making the cut and many thanks to all the other submissions for taking the time to enter.

Inessa Lurye, senior director of product and head of women’s health at Hinge Health

Hinge Health is a digital clinic for joint and muscle pain on a mission to reduce musculoskeletal pain, opioid use and surgeries by pairing advanced wearable technology with a comprehensive clinical care team.

Sylvia Kang, founder and CEO of Mira 

Mira is a San Francisco-based health start-up providing integrative care and hormonal testing. The company aims to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives.

Dr Jennifer Hintzsche, founder and CEO of PherDal Fertility

PherDal is developing the first FDA-cleared, at-home fertility treatment. Its technology aims to bring assisted reproduction back into the home as an affordable, over-the-counter fertility treatment.

Athena Doshi, founder and CEO of Celeste

Celeste is a start-up which uses AI-powered precision medicine to enable healthcare providers and payers to assess how a patient will respond to medications and subsequently create personalised adherence plans.

Continue Reading

Femtech World Awards

Femtech World reveals Fertility Innovation shortlist



Six fertility innovators have made the shortlist for Femtech World’s Fertility Innovation award sponsored by Apryl. Check them out below.  

Apryl is a fertility benefits platform that helps employers attract and retain top talent while tackling diversity and inclusion.

The company helps employers support their employees with fertility and family planning benefits, including consultation, access to clinics, treatments and adoption.

Through the Fertility Innovation Award, sponsored by Apryl, Femtech World aims to shine a light on the life-changing work of those developing innovative fertility solutions.

The six finalists will now go-head-to-head, with the winner announced at a virtual ceremony on May 2.


Selectivity is a start-up focused on universalising access to fertility treatments. The company is working towards developing better, accessible and cost-saving assisted reproductive devices that are promising to transform the patient journey to conception. 

Future Fertility is the first company in the world to address this significant gap in treatment planning and patient expectation management by developing AI-powered oocyte assessment software that provides patients and their fertility care teams with personalised egg quality insights.

The software uses deep learning technology to analyse 2D images of mature oocytes, providing egg quality scores that have been validated in laboratories and clinical practice and are proven to correlate directly with reproductive outcomes.

Proov is a diagnostics company offering medical grade at-home tests and a support platform that is clinically proven to help those looking to conceive do so faster and more cost-effectively.

Proov founder, Dr Amy Beckley, PhD, created the core Proov technology after her own battle with infertility. The company now boasts over 10 products and continues to innovate to bring additional solutions to child bearing people and their partners.

Fairtility is advancing reproductive care through the power of transparent AI to help clinicians and their patients on the reproductive care journey.

The company believes that transparency is critical when AI intersects with human life. Its flagship software, CHLOE, is a transparent AI-based decision support tool providing clinicians with visibility into clinical and laboratory parameters crucial to improving reproductive care outcomes in IVF, fertility preservation and egg donation.

Embie aims to optimise fertility treatments with personalised, connected care. The Embie Clinic platform seeks to empower clinics with real-time, data driven insights, while reducing the administrative and cognitive load for the clinic.

Plan Your Baby is a telehealth fertility clinic on a mission to reduce practical and financial barriers to IVF.

The platform leverages cutting-edge technology to provide support from preconception to birth, while addressing 13 of the main treatable causes of infertility.

Continue Reading

Femtech World Awards

Seven start-ups to go head-to-head at Femtech World Awards



Seven femtech start-ups have made the shortlist for Femtech World’s OB/GYN Innovation award sponsored by Cross-Border Impact Ventures

CrossBorder Impact Ventures is on a mission to revolutionise venture capital investing in health technology. The company invests in early-growth stage health technology companies commercialising medical devices, diagnostics, therapeutics and digital health innovations and leveraging cutting-edge technologies like AI and machine learning.

All financed innovations are relevant to women, children and adolescent health and located in North America, Europe and Israel with ability to scale technologies to Emerging Markets.

The shortlisted companies in the OB/GYN Innovation category stood out among some truly remarkable entries from all over the world.

The seven shortlisted entries will soon be judged by the category sponsor, with the ultimate winner announced at a virtual event on May 2.


Nesa Medtech is a a medical device start-up on a mission to transform women’s health by developing minimally invasive surgical solutions.

The company’s flagship product is a novel, minimally invasive and uterus-preserving technology aimed at treating uterine fibroids, a condition which has profound impacts on healthcare delivery and costs worldwide.

EndoCure aims to revolutionise the diagnosis of endometriosis with a novel robotic AI-powered ultrasound. The system is specifically designed to detect endometriosis lesions, which currently can’t be detected by imaging tools.

The ability to detect such lesions, EndoCure says, is crucial as the pain associated with endometriosis can be excruciating and life-altering. This capability not only promises to shorten the diagnostic journey for millions of women suffering from endometriosis but also aims to enhance the accuracy of diagnosis.

Hale offers a virtual-first care model that aims to reshape patient journeys for gynaecological conditions.

The platform leverages cutting-edge technology and interdisciplinary expertise to provide comprehensive care solutions, including online consultations, care navigation support, digital prescriptions and diagnostic fast-tracking processes.


Lasa Health is a health tech company supporting the diagnosis and management of pelvic pain disorders. The company uses AI and machine learning to screen patients for the potential causes of chronic pelvic pain.

Its algorithm, according to its developers, is able to catch conditions that would have otherwise been missed by physicians. The platform provides personalised recommendations for physicians to review and discuss with patients. 

Sonio is an AI solution for prenatal screening and diagnosis with over five years of research and collaborations between leading experts in foetal medicine and AI.

Sonio’s goal is to support foetal ultrasound practitioners in prenatal screening and diagnosis by assuring the completeness of their examination and increasing the accuracy of their patient scan results.

Based in Switzerland, Aspivix is a medical device company on a mission to reimagine and modernise gynaecology.

Its flagship product, Carevix, is the world’s first suction cervical stabiliser clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynaecology, including IUD insertion, hysteroscopy, cervical biopsies and fertility treatments.

Yeda is developing a sustainable device that aims to support women’s pelvic floor and improve bladder control. The company is committed to improving women’s quality of life by offering personalised and user-friendly treatment.

Its device promises to disrupt the market by reducing hospital visits and providing gynaecologists with an innovative tool for their patients.

Continue Reading

Trending Posts

Receive updates from Femtech World

Sign up for updates from Femtech World


Copyright © 2023 Aspect Publishing Ltd. All Rights Reserved.